These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32208799)
1. Diagnostic value of urinary monocyte chemoattractant protein-1 in evaluating the activity of lupus nephritis: a meta-analysis. Xia YR; Li QR; Wang JP; Guo HS; Bao YQ; Mao YM; Wu J; Pan HF; Ye DQ Lupus; 2020 May; 29(6):599-606. PubMed ID: 32208799 [No Abstract] [Full Text] [Related]
2. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients. Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812 [TBL] [Abstract][Full Text] [Related]
3. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
4. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Singh RG; Usha ; Rathore SS; Behura SK; Singh NK Lupus; 2012 Oct; 21(11):1214-8. PubMed ID: 22759858 [TBL] [Abstract][Full Text] [Related]
5. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis. Dong XW; Zheng ZH; Ding J; Luo X; Li ZQ; Li Y; Rong MY; Fu YL; Shi JH; Yu LC; Wu ZB; Zhu P Lupus; 2018 May; 27(6):971-981. PubMed ID: 29451067 [TBL] [Abstract][Full Text] [Related]
6. Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis. Lee YH; Song GG Z Rheumatol; 2017 May; 76(4):357-363. PubMed ID: 27278779 [TBL] [Abstract][Full Text] [Related]
7. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus. Vincent FB; Kandane-Rathnayake R; Hoi AY; Slavin L; Godsell JD; Kitching AR; Harris J; Nelson CL; Jenkins AJ; Chrysostomou A; Hibbs ML; Kerr PG; Rischmueller M; Mackay F; Morand EF Lupus; 2018 Nov; 27(13):2029-2040. PubMed ID: 30301439 [TBL] [Abstract][Full Text] [Related]
8. International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021 [TBL] [Abstract][Full Text] [Related]
9. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Marks SD; Shah V; Pilkington C; Tullus K Pediatr Nephrol; 2010 Nov; 25(11):2283-8. PubMed ID: 20683619 [TBL] [Abstract][Full Text] [Related]
10. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. Watson L; Midgley A; Pilkington C; Tullus K; Marks S; Holt R; Jones C; Beresford M Lupus; 2012 Apr; 21(5):496-501. PubMed ID: 22147846 [TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263 [TBL] [Abstract][Full Text] [Related]
13. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301 [TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study. Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621 [TBL] [Abstract][Full Text] [Related]
15. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis. Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021 [TBL] [Abstract][Full Text] [Related]
16. Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis. Abozaid MA; Ahmed GH; Tawfik NM; Sayed SK; Ghandour AM; Madkour RA Egypt J Immunol; 2020 Jan; 27(1):97-107. PubMed ID: 33180392 [TBL] [Abstract][Full Text] [Related]
17. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis. Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity. Gupta R; Yadav A; Aggarwal A Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649 [TBL] [Abstract][Full Text] [Related]
19. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis. Alzawawy A; Zohary M; Ablordiny M; Eldalie M Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368 [TBL] [Abstract][Full Text] [Related]
20. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Kim HL; Lee DS; Yang SH; Lim CS; Chung JH; Kim S; Lee JS; Kim YS Am J Kidney Dis; 2002 Dec; 40(6):1146-52. PubMed ID: 12460032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]